๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A Risk-Benefit Assessment of Risperidone for the Treatment of Behavioural and Psychological Symptoms in Dementia

โœ Scribed by Dr Michael Zaudig

Book ID
119925185
Publisher
Springer International Publishing AG
Year
2000
Tongue
English
Weight
177 KB
Volume
23
Category
Article
ISSN
0114-5916

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Assertion that risperidone is superior t
Assertion that risperidone is superior to haloperidol for treatment of behavioural and psychological symptoms of dementia
โœ Graham A. Jackson ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 48 KB ๐Ÿ‘ 1 views

## Dear Editor I feel I cannot let the assertion that risperidone is superior to haloperidol for treatment of behavioural and psychological symptoms of dementia (Suh et al., 2006) go unchallenged. This paper shows no such thing. There is a very basic flaw, which means that all findings are invali

A double-blind randomised comparison of
A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients
โœ Wai-chi Chan; Linda Chiu-wa Lam; Caroline Nga-pui Choy; Vivian Pui-yiu Leung; Si ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 76 KB ๐Ÿ‘ 1 views

## Abstract ## Background Behavioural and psychological symptoms (BPSD) are common during the course of dementia and present severe problems to patients and their caregivers. ## Objectives To assess the therapeutic efficacy and safety of haloperidol and risperidone in treating BPSD in Chinese de